Overview

Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial

Status:
Not yet recruiting

Trial end date:
2022-10-01

Target enrollment:

Participant gender:

Summary

This study is a randomized, placebo-controlled, double-blind, multicenter phase III clinical trial of Yiqi Wenjing prescriptions for Preventing Oxaliplatin-induced Peripheral Neuropathy.

Phase:

Phase 3

Details

Lead Sponsor:

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Collaborators:

Fudan University
Jiangsu Cancer Institute & Hospital
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The First Affiliated Hospital with Nanjing Medical University